Literature DB >> 21556542

Functional expression of sv40 in normal human prostatic epithelial and fibroblastic cells - differentiation pattern of nontumorigenic cell-lines.

P Berthon1, O Cussenot, L Hopwood, A Leduc, N Maitland.   

Abstract

To study mesenchymal-epithelial interactions associated with the normal and pathological human prostate, we have developed a model of well differentiated human prostate epithelial and fibroblastic cells. Normal human prostatic cells, either of epithelial or fibroblastic origins were successfully transfected with SV40 and strains with extended lifespan were selected until the crisis was reached, within 20 and 30 passages for the epithelial and fibroblastic cells, respectively. Only a few clones emerged from the crisis: PNT1A (Cussenot et al: J Urol 143: 881-886, 1991), PNT1B and PNT2 epithelial cell lines. Successful immortalisation was achieved only with SV40 expressing both large T and small t oncogenes, while attempts to immortalise with a vector expressing SV40 large T alone have given a few strains showing no extended lifespan and no cells which overcame the crisis. A PNT2 subclone named PNT2-LSD which developed spontaneously (less serum dependent) was selected, characterised and included in the analysed series. The epithelial cell lines displayed a differentiation pattern which has been classified as follows (from high to low): PNT2>PNT2-LSD>PNT1A>PNT1B. Differentiation features studied were (i) the colony-forming ability of the PNT2 and PNT2-LSD compared to PNT1A and PNT1B, (ii) their respective doubling time of 39, 29, 30 and 28 hours, (iii) their decreasing serum dependency, (iv) the expression of cytokeratin 19 (a feature of well differentiated luminal cells of the glandular prostate) for PNT2 and PNT2-LSD. Furthermore, the mesenchymal derived pflsv1 cells were confirmed to be of fibroblastic nature. None of the cell lines analysed showed any tumourigenicity in nude mice over a period of 12 months. Serum deprivation and direct steroid withdrawal during the culture triggered cell death by apoptosis, an event which could be overcome by EGF stimulation, particularly for the well differentiated PNT2 cells. This interesting characteristic, which is similar to the high apoptotic rate observed ipl vivo for normal prostate, particularly after castration should lead, together with the other properties of these cell lines, to a better understanding of the biology of the different cell compartments involved in the progression of prostate towards neoplasia.

Entities:  

Year:  1995        PMID: 21556542     DOI: 10.3892/ijo.6.2.333

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  30 in total

1.  PARP-1 and CASP3 genes are up-regulated in LNCaP and PC-3 prostate cancer cell lines.

Authors:  Michele Salemi; Rosita A Condorelli; Sandro La Vignera; Nunziata Barone; Federico Ridolfo; Maria C Giuffrida; Enzo Vicari; Aldo E Calogero
Journal:  Hum Cell       Date:  2014-07-19       Impact factor: 4.174

2.  Prostate tumorigenesis induced by PTEN deletion involves estrogen receptor β repression.

Authors:  Paul Mak; Jiarong Li; Sanjoy Samanta; Cheng Chang; D Joseph Jerry; Roger J Davis; Irwin Leav; Arthur M Mercurio
Journal:  Cell Rep       Date:  2015-03-26       Impact factor: 9.423

3.  Chk1 targeting reactivates PP2A tumor suppressor activity in cancer cells.

Authors:  Anchit Khanna; Otto Kauko; Camilla Böckelman; Anni Laine; Ilona Schreck; Johanna I Partanen; Agnieszka Szwajda; Stefanie Bormann; Turker Bilgen; Merja Helenius; Yuba R Pokharel; John Pimanda; Mike R Russel; Caj Haglund; Kristina A Cole; Juha Klefström; Tero Aittokallio; Carsten Weiss; Ari Ristimäki; Tapio Visakorpi; Jukka Westermarck
Journal:  Cancer Res       Date:  2013-09-26       Impact factor: 12.701

4.  Utilizing custom-designed galvanotaxis chambers to study directional migration of prostate cells.

Authors:  Hsin-ya Yang; Thi Dinh La; R Rivkah Isseroff
Journal:  J Vis Exp       Date:  2014-12-07       Impact factor: 1.355

5.  Androgen-induced TMPRSS2:ERG fusion in nonmalignant prostate epithelial cells.

Authors:  Nuria Coll Bastus; Lara K Boyd; Xueying Mao; Elzbieta Stankiewicz; Sakunthala C Kudahetti; R Tim D Oliver; Daniel M Berney; Yong-Jie Lu
Journal:  Cancer Res       Date:  2010-10-14       Impact factor: 12.701

6.  Leucine zipper, down regulated in cancer-1 gene expression in prostate cancer.

Authors:  Michele Salemi; Nunziata Barone; Sandro La Vignera; Rosita A Condorelli; Domenico Recupero; Antonio Galia; Filippo Fraggetta; Anna Maria Aiello; Pietro Pepe; Roberto Castiglione; Enzo Vicari; Aldo E Calogero
Journal:  Oncol Lett       Date:  2016-08-10       Impact factor: 2.967

7.  Estrogen receptor β sustains epithelial differentiation by regulating prolyl hydroxylase 2 transcription.

Authors:  Paul Mak; Cheng Chang; Bryan Pursell; Arthur M Mercurio
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-04       Impact factor: 11.205

8.  UAP1 is overexpressed in prostate cancer and is protective against inhibitors of N-linked glycosylation.

Authors:  H M Itkonen; N Engedal; E Babaie; M Luhr; I J Guldvik; S Minner; J Hohloch; M C Tsourlakis; T Schlomm; I G Mills
Journal:  Oncogene       Date:  2014-09-22       Impact factor: 9.867

9.  Deregulation of MicroRNAs mediated control of carnitine cycle in prostate cancer: molecular basis and pathophysiological consequences.

Authors:  A Valentino; A Calarco; A Di Salle; M Finicelli; S Crispi; R A Calogero; F Riccardo; A Sciarra; A Gentilucci; U Galderisi; S Margarucci; G Peluso
Journal:  Oncogene       Date:  2017-07-03       Impact factor: 9.867

10.  Evaluating baculovirus as a vector for human prostate cancer gene therapy.

Authors:  Stephanie L Swift; Guillermo C Rivera; Vincent Dussupt; Regina M Leadley; Lucy C Hudson; Corrina Ma de Ridder; Robert Kraaij; Julie E Burns; Norman J Maitland; Lindsay J Georgopoulos
Journal:  PLoS One       Date:  2013-06-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.